Tonix Pharmaceuticals Holding Corp Stock Nasdaq
Equities
US8902602015
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2024 * | 16.33M 22.31M | Sales 2025 * | 18.2M 24.86M | Capitalization | 17.53M 23.94M |
---|---|---|---|---|---|
Net income 2024 * | -96M -131M | Net income 2025 * | -88M -120M | EV / Sales 2024 * | 1.07 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.96 x |
P/E ratio 2024 * |
-0.18
x | P/E ratio 2025 * |
-0.27
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.99% |
1st Jan change | Capi. | |
---|---|---|
-3.89% | 88.14B | |
+1.45% | 40.51B | |
-15.16% | 31.67B | |
+51.27% | 24.62B | |
-14.27% | 15.65B | |
-14.38% | 12.07B | |
-7.87% | 11.97B | |
-39.40% | 11.61B | |
+5.92% | 8.81B |